The AGM100 is designed to assess the cardiorespiratory status of patients, including the identification of hypoxia, its severity, and source. It is particularly useful for conditions that affect pulmonary gas exchange, such as COPD, pneumonia, pulmonary embolism, or heart failure, where the transfer of oxygen from the lungs to the blood is immediately detectable.
The measurement of Oxygen Deficit, provided by the AGM100, indicates the severity of impairment and offers a more comprehensive and precise view of cardiorespiratory status by including the oxygen levels of both the lungs (PAO2) and blood (PaO2), rather than relying solely on blood oxygenation levels.
The measurement of MediPines Oxygen Deficit, provided by the AGM100, is the most informative and comprehensive assessment of gas exchange.
The measurement of MediPines Oxygen Deficit, provided by the AGM100, is the most informative and comprehensive assessment of gas exchange.
Fast, non-invasive assessment of a patient's cardiorespiratory status.
Blood oxygenation, ventilation, and gas exchange simultaneously
Determine cardiorespiratory severity using O2 Deficit (non-invasive A-a gradient)
Establish clear baseline patient measurement prior to procedure
2-minute test allows MA to collect data and update chart before being seen by the MD
Automatic steady state recognition for repeatable result to test treatment effectiveness
Immediate results in office for faster clinical decisions
Fully reimbursable procedure
Reduce the number of patients sent to lab or ER for similar information
Objective, repeatable test improves monitoring patients over time
Use O2 Deficit to make home/observe/admission decisions
Use O2 Deficit to predict the need for escalated care like supplemental oxygen
Identify hypoxic condition and sources of hypoxemia to direct treatment
Use O2 Deficit for differential diagnosis e.g., NSTEMI vs PE
Determine cardiorespiratory severity using O2 Deficit (non-invasive A-a gradient)
Add clarity in diffuse chief complaints like shortness of breath or chest pain
Used with quick response team to help identify the chief problem
Use O2 Deficit as a surrogate for V/Q matching
Objective, repeatable test improves monitoring patients over time
Risk stratify surgical patients for postoperative pulmonary complications
Preoperative evaluation to determine oxygenation strategies
Establish baseline measurement prior to anesthesia
Monitor for residual shunt from the intra-operative period
Early identification of atelectasis leading to hypoxemia
Monitor for post-anesthesia hypoventilation
Confirm gas exchange efficiency before patient discharge
Reduce avoidable postoperative pulmonary complications
Confirm pharmacological effectiveness
Identify hypoxic condition and sources of hypoxemia to direct treatment
Complement ultrasound to determine severity using O2 Deficit (non-invasive A-a gradient)
Establish clear baseline patient measurement prior to procedure
Confirm degree of the blockage being treated
Identify secondary blockages with changes in gas exchange
Maintain stable V/Q matching before ending the procedure
Confirm pharmacological effectiveness before patient discharge
Use oxygen deficit to approximate pulmonary vascular pressures
Manage fluid buildup (edema) in heart failure to avoid readmission